Remove Biotechnology Remove Health Data Remove Hospitals Remove Life Sciences
article thumbnail

Freenome Launches Multi-Cancer Detection Study Pairing Multiomics with Real-World Data

HIT Consultant

Freenome is a biotechnology company with a comprehensive multiomics platform for the early detection of cancer using a standard blood draw. to advance research and increase equitable access to clinical trials by contributing de-identified data to the LHN. A Comprehensive Multiomics Platform for the Early Detection of Cancer.